New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024
Important new results and an update on an EORTC [...]
Important new results and an update on an EORTC [...]
EORTC’s presence at this year’s ESMO Congress 2024, taking [...]
The year 2024 signals the beginning of a new [...]
The EORTC Annual Report represents a valuable opportunity to [...]
Dr Denis Lacombe, CEO of EORTC, has been appointed [...]
Treatment optimisation research seeks to benefit patients and healthcare [...]
We are delighted to announce EORTC's participation at the [...]
Since 2001, EORTC and Kom op tegen Kanker have supported [...]
In a significant stride towards advancing cancer research and [...]
EORTC is very proud to inform you that seven [...]